Sonim Technologies Inc
SONM at a Glance
- Market cap
- $3.8M
- Revenue (TTM)
- $-11,190,000
- EPS (TTM)
- $-0.63
- 52-week range
- $3 – $12
- Street target
- $8.00
- Next report
- Nov 6, 2026
Headquartered in San Diego, CA Fiscal year ends December NASDAQ: SONM ir.dna-x.global
About DNA X
DNA X, Inc. (Nasdaq: SONM), formerly Sonim Technologies Inc., is a provider of cryptocurrency trading services operating the DNA X AI trading platform. The company completed a strategic transformation in January 2026, divesting its legacy mobile device design and manufacturing business to NEXA Mobility and rebranding to DNA X. The platform is designed to harness advanced AI and machine learning technologies to automate intelligent trading strategies, enabling clients to capitalize on data-driven insights and dynamic opportunities in decentralized AI and crypto trading. The company plans to launch an enhanced version of its platform to the public later in 2026. DNA X accounts for its AI platform activities as an investment reflected in other income through its equity method investment in DNA X LLC. Updated
Frequently Asked Questions
What does DNA X do?
DNA X, Inc. (Nasdaq: SONM), formerly Sonim Technologies Inc., is a provider of cryptocurrency trading services operating the DNA X AI trading platform.
What is the SONM stock price target?
The Wall Street consensus 12-month price target for SONM is $8.00.